These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 19619601)
21. Roles of the three major phosphorylation sites of hepatitis B virus core protein in viral replication. Lan YT; Li J; Liao W; Ou J Virology; 1999 Jul; 259(2):342-8. PubMed ID: 10388659 [TBL] [Abstract][Full Text] [Related]
22. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication. Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970 [TBL] [Abstract][Full Text] [Related]
23. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice. Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF Chin Med J (Engl); 2005 Aug; 118(16):1351-6. PubMed ID: 16157029 [TBL] [Abstract][Full Text] [Related]
24. Use of dominant negative mutants of the hepadnaviral core protein as antiviral agents. Scaglioni P; Melegari M; Takahashi M; Chowdhury JR; Wands J Hepatology; 1996 Nov; 24(5):1010-7. PubMed ID: 8903368 [TBL] [Abstract][Full Text] [Related]
25. Identification of nucleophosmin/B23, an acidic nucleolar protein, as a stimulatory factor for in vitro replication of adenovirus DNA complexed with viral basic core proteins. Okuwaki M; Iwamatsu A; Tsujimoto M; Nagata K J Mol Biol; 2001 Aug; 311(1):41-55. PubMed ID: 11469856 [TBL] [Abstract][Full Text] [Related]
26. [Antiviral effects of dual-target antisense rna: an experimental study with hepatitis B virus transgenic mice]. Zhao W; Chen H; Peng ZY; Li WG; Xi HL; Xu XY Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3486-90. PubMed ID: 16686065 [TBL] [Abstract][Full Text] [Related]
27. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication. Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991 [TBL] [Abstract][Full Text] [Related]
28. [An in vitro model of hepatitis B virus gene replication and expression in primary rat hepatocytes transfected with circular viral DNA]. Yao YQ; Zhang DF; Luo Y; Zhang DZ; Huang AL; Wang B; Zhou WP; Ren H; Guo SH Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):275-8. PubMed ID: 12223138 [TBL] [Abstract][Full Text] [Related]
29. Synergistic effect of radiation and interleukin-6 on hepatitis B virus reactivation in liver through STAT3 signaling pathway. Chou CH; Chen PJ; Jeng YM; Cheng AL; Huang LR; Cheng JC Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1545-52. PubMed ID: 19327909 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of hepatitis B virus replication by targeted pretreatment of complexed antisense DNA in vitro. Nakazono K; Ito Y; Wu CH; Wu GY Hepatology; 1996 Jun; 23(6):1297-303. PubMed ID: 8675142 [TBL] [Abstract][Full Text] [Related]
31. Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice. Shin D; Kim SI; Kim M; Park M Virus Res; 2006 Aug; 119(2):146-53. PubMed ID: 16443303 [TBL] [Abstract][Full Text] [Related]
32. Effect of mutating the two cysteines required for HBe antigenicity on hepatitis B virus DNA replication and virion secretion. Bang G; Kim KH; Guarnieri M; Zoulim F; Kawai S; Li J; Wands J; Tong S Virology; 2005 Feb; 332(1):216-24. PubMed ID: 15661154 [TBL] [Abstract][Full Text] [Related]
33. [Anti-HBV effects of genetically engineered replication-defective HBV with combined expression of antisense RNA and dominant negative mutants of core protein and construction of first-generation packaging cell line for HBV vector]. Sun DX; Hu DR; Wu GH; Hu XL; Li J; Fan GR Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):260-4. PubMed ID: 12223133 [TBL] [Abstract][Full Text] [Related]
34. Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene. Günther S; Piwon N; Jung A; Iwanska A; Schmitz H; Will H Virology; 2000 Aug; 273(2):286-99. PubMed ID: 10915599 [TBL] [Abstract][Full Text] [Related]
35. Low level wild-type and pre-core mutant hepatitis B viruses and HBeAg negative reactivation of chronic hepatitis B. Oketani M; Oketani K; Xiaohong C; Arima T J Med Virol; 1999 Aug; 58(4):332-7. PubMed ID: 10421398 [TBL] [Abstract][Full Text] [Related]
36. Recent studies on replication of hepatitis B virus. Kann M; Lu X; Gerlich WH J Hepatol; 1995; 22(1 Suppl):9-13. PubMed ID: 7602085 [TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Walter E; Keist R; Niederöst B; Pult I; Blum HE Hepatology; 1996 Jul; 24(1):1-5. PubMed ID: 8707245 [TBL] [Abstract][Full Text] [Related]
38. [The inhibitory effects on hepatitis B virus replication by stable expression of DN mutants of hepatitis B virus X gene pRev X-GFP]. Song JW; Lin JS; Kong XJ; Liang KH Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):392-4. PubMed ID: 15268799 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of vaccinia virus replication by peptide aptamers. Saccucci L; Crance JM; Colas P; Bickle M; Garin D; Iseni F Antiviral Res; 2009 Jun; 82(3):134-40. PubMed ID: 19428604 [TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus core and E2 protein expression in transgenic mice. Pasquinelli C; Shoenberger JM; Chung J; Chang KM; Guidotti LG; Selby M; Berger K; Lesniewski R; Houghton M; Chisari FV Hepatology; 1997 Mar; 25(3):719-27. PubMed ID: 9049225 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]